Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Index Funds median (271 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 25 Oct 2024 – 20 Aug 2026, limited by Mirae Asset Nifty 50 Index Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Mirae Asset Nifty 50 Index Fund | Nifty 50 |
|---|---|---|
| 25 Oct 2024 | ₹100.00 | ₹100.00 |
| 19 Dec 2024 | ₹99.04 | ₹99.05 |
| 13 Feb 2025 | ₹95.29 | ₹95.25 |
| 09 Apr 2025 | ₹92.54 | ₹92.63 |
| 03 Jun 2025 | ₹101.50 | ₹101.50 |
| 29 Jul 2025 | ₹102.94 | ₹102.65 |
| 22 Sep 2025 | ₹104.58 | ₹104.22 |
| 16 Nov 2025 | ₹107.55 | ₹107.15 |
| 11 Jan 2026 | ₹106.51 | ₹106.21 |
| 07 Mar 2026 | ₹101.40 | ₹101.12 |
| 01 May 2026 | ₹99.40 | ₹99.24 |
| 26 Jun 2026 | ₹99.94 | ₹99.48 |
| 20 Aug 2026 | ₹100.87 | ₹100.21 |
| Metric | Mirae Asset · Regular · IDCW NAV ₹10.00 Very High risk ★★☆☆☆ 1Y | Category median Index Funds · 271 funds |
|---|---|---|
| -3.01% | +4.72% | |
| — | +7.52% | |
| — | +8.28% | |
| — | +9.00% | |
| +0.48% | +7.27% | |
| -0.35% | — | |
| — | +7.88% | |
| — | +10.94% | |
| — | +9.63% | |
| Risk | ||
| 13.32% | 13.54% | |
| -0.71 | 0.11 | |
| -1.00 | 0.15 | |
| -15.20% | -15.67% | |
| Nifty 50 | — | |
| — | -0.05% | |
| — | 1.00 | |
| — | 101.3% | |
| — | 99.5% | |
| 0.87% | 0.88% | |
| ₹62.89Cr | ₹181.49Cr | |
| None | — | |
| None | — | |
| ₹99 | — | |
| ₹5.00K | — | |
| — | 38% | |
| Ekta Gala · 1.9y | — | |
| 25 Oct 2024 | — | |
| 50 | — | |
| 53.4% | — | |
| 0.3% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.